Share Your Research, Maximize Your Social Impacts
The Impact of Epstein Barr-Virus on Therapeutic Options of Lymphoma |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.8, No. 1)Publication Date: 2020-03-09
Authors : Ahed J Alkhatib; Marwa Yousry Mohamed; Ghormallah Abdullah AlGhamdi;
Page : 59-61
Keywords : Lymphoma; EBV; Prevalence; Immunosuppression; Apoptosis;
Source : Download
Find it from : Google Scholar
Abstract
This review study aimed to investigate the impacts of having Epstein Bar-Virus (EBV) positivity on therapeutic options of lymphomas. About one third of lymphomas are positive for EBV. Anyhow, existing therapeutic options are almost similar for treating lymphomas as either positive or negative for EBV. Future trends are thought to differ based on more better understanding of biology of EBV and to target such mechanisms that counteract or interfere with its pathogenesis including activation of apoptotic pathways or activating immunosuppression mechanisms.
Other Latest Articles
- REAL-TIME EMISSIONS OF GASEOUS POLLUTANTS FROM VEHICLES UNDER HETEROGENEOUS TRAFFIC CONDITIONS
- Free Science from Dogma. or: How the “Pseudogene” Hampered Scientific Progress |Biomedgrid
- The Reality of The New Corona Virus (N Co V-2019) Diagnosis, Treatment, and Prevention |Biomedgrid
- Targeting Cancer Through Autophagy With Β-Elemene and Puerarin |Biomedgrid
- Correlation between In-vitro and In-vivo Studies based on Pharmacokinetic Considerations |Biomedgrid
Last modified: 2023-06-01 21:49:51